by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
see Patient Voice Initiative.
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
see Pathology Services Table.
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
see Public Summary Document.
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
Information available to the public about recommendations from PBAC or MSAC.
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
see Patient reported outcome measure.
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
The likelihood that an event will occur. In statistics, the probability (or P‐value) shows the likelihood that a research result could have occurred by chance alone. For example, a P‐value of 0.05 means there is a five in 100 chance that the effect observed in the...
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
A study that collects data and analyses it. It can refer to either laboratory research or clinical trials. HTAI
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
The result(s) of most interest to the researchers. A test or treatment can give results for several outcomes, but primary outcomes are of greatest importance when assessing the outcome. HTAI
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
A study that looks at how common a disease or condition is in a population. HTAI
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
How common a disease or condition is within a population either at a point in time or over a given period of time (it includes new and existing cases). For example, in 2007, the prevalence of diabetes in Scottish heath boards varied from 3.7% to 4.6%. HTAI
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
Patient and public Involvement.
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
A group of people with a common link, such as the same medical condition or living in the same area or sharing the same characteristics. The population for a clinical trial is all the people whom the test or treatment is designed to help (such as adults with diabetes,...
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
see Post Market Surveillance.
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
The activity of monitoring the performance of a health technology post-approval. CoA
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
see Protheses List Advisory Committee.
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
An independent HTA advisory committee of the Australian Government that primarily makes recommendations to the health minister on appropriate listing of, and benefits for, prostheses in the Prostheses List. CoA
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
see Protheses List.
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
Under the authority of the Private Health Insurance Act 2007, a listing of the prostheses that private health insurers must fund and the benefits payable for them. CoA
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
see Population, intervention, comparator, outcome
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
A framework used, especially in evidence-based medicine, to guide research questions and literature searches.
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
A document that provides health professionals with a summary of the scientific information relevant to the safe and effective use of a prescription medicine.
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
see Product information or patient involvement.
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
see Pharmaceutical Benefits Scheme.
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
Different phases of clinical trials that are run to develop a new test or treatment, such as a drug. Phase I (one) involves using healthy human volunteers to check the safety of the test or treatment. In phases II–IV (two to four), patients with the disease that the...
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
Under the authority of the National Health Act 1953, a listing and description of the medicines that are subsidised by the Australian Government, the amount of that subsidy and any conditions applying to the use of that medicine. PBS
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
An independent HTA advisory committee of the Australian Government that primarily makes recommendations to the health minister on the listing of medicines in the PBS. PBS
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
see Pharmaceutical Benefits Advisory Committee.
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
An incorporated association which brings together patients, patient groups, researchers and industry to promote and improve the use of the patient voice in healthcare decision making in Australia.
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
A measurement based on a report that comes directly from the patient (i.e., study subject) about the status of a patient’s health condition without amendment or interpretation of the patient’s response by a clinician or anyone else. PROM is the instrument or tool,...
by Patient Voice Initiative | Sep 3, 2019 | Glossary, P
A range of methods to measure the values of patients with a particular condition to explore how they perceive treatments and to understand what is most important to them.
